fda semaglutide warning september 2025 There's lots going on this month at in the world of weight loss drugs. The agency is taking a hard look at the market. Check out these new #FDA Letters FDA Issues 30 Warning Letters

Available data are insufficient to inform recommendations to mitigate the risk of pulmonary aspiration during general anesthesia or deep sedation in patients taking RYBELSUS or OZEMPIC tablets, including whether modifying preoperative fasting recommendations or temporarily discontinuing RYBELSUS or OZEMPIC tablets could reduce the incidence of retained gastric contents

Coverage for Wegovy and Zepbound on marketplace plans varies by plan tier and state

doi: 10.14309/crj.0000000000000868 33 PRISMA 2020 checklist

It produces it locally right at the site where its needed or releases it directly into the bloodstream from cells or glands

However, they will not address any underlying causes of the headache, like dehydration